Newly released survey data commissioned by the Alliance for Safe Online Pharmacies (ASOP Global) Foundation shows more Americans are buying prescription medication online than ever. That number is rising, driven by cost and convenience, accelerated by the pandemic, and fueled by drug shortages and changes in access. However, most consumers make dangerous, false assumptions about the safety, oversight, and compliance of online drug sellers and the serious health risks posed by medications purchased through illegal sources online.
Through advocacy, education, and policy, the Alliance for Safe Online Pharmacies (ASOP Global) works to disrupt illegal online drug sellers’ schemes and has submitted comments to the United States Patent and Trademark Office (USPTO) outlining challenges and solutions to achieve that mission.
The U.S. Senate Judiciary Committee held a markup of S.1080, the Cooper Davis Act. The Alliance for Safe Online Pharmacies (ASOP Global) applauds the Senate Judiciary Committee for pushing Big Tech to take a more proactive role against illegal online drug sellers.
ASOP Global participated in the Federal Drug Administration’s fourth Online Controlled Substances Summit. This year, the FDA broadened its focus from opioids to all controlled substances. As part of the summit’s expanded scope, the Center for Drug Evaluation and Research, the United Nations’ Global OPIOIDS Project, U.S. Customs and Border Protection, and other experts examined global trends and policy and law enforcement solutions for stopping the illegal online sale of opioids and other controlled substances.
ASOP Global has named Susan Wilson to its Board of Directors. For more than 30 years, Susan served in technical and leadership positions at the Department of Commerce’s U.S. Patent & Trademark Office and International Trade Administration, the Office of the United States Trade Representative (USTR), the Departments of State and Justice, and the U.S. Customs Service. She is currently a director of intellectual property policy at Intel Corporation.
The Alliance for Safe Online Pharmacies supports the bipartisan Cooper Davis Act as an important weapon to help federal, state, and local law enforcement fight the illegal online sale of counterfeit medicine laced with potentially deadly doses of fentanyl.
Judge Karas’ dismissal of PharmacyChecker.com’s baseless lawsuit confirms what ASOP Global has known from the start: “PharmacyChecker.com makes most of its money by helping people illegally import drugs.”
Judge Matthew J. Kacsmaryk’s decision to revoke U.S. Food and Drug Administration (FDA) approval for mifepristone undermines nearly 120 years of FDA legal authority and threatens the health and safety of American women.
ASOP commends theU.S. House of Representatives for passing H.R. 5502, the Integrity, Notification, and Fairness in Online Retail Marketplaces (INFORM) for Consumers Act. The bipartisan bill requires online marketplaces to verify high-volume sellers and provide consumers with their contact information. The legislation also enables law enforcement to prosecute criminals and remove counterfeit, dangerous, or defective products from online marketplaces.
A new report by The National Association of Boards of Pharmacy (NABP), sponsored by ASOP Global Foundation, shows that locking and suspending websites that illegally sell prescription medications online directly impacts patient safety.
ASOP EU is delighted to announce that Stefan Feltens, the President of the European Association of E-Pharmacies (EAEP) will become a Director of ASOP EU, adding significant influence to this important patient safety initiative.
The Alliance for Safe Online Pharmacies (ASOP Global) welcomed pioneering global pharmaceutical company Moderna as a new member organization today, expanding the company’s long-standing leadership on patient safety issues.
The Alliance for Safe Online Pharmacies (ASOP) is thrilled to congratulate President of the Board of Directors, John Hertig, PharmD, MS, FASHP, and Board Member Ilisa Bernstein on their recent promotions. Hertig has been named Chair of Pharmacy Practice in Butler University’s College of Pharmacy and Health Sciences (COPHS). Bernstein, PharmD, JD, FAPhA, has been named Interim CEO of the American Pharmacists Association (APhA).
The Alliance for Safe Online Pharmacies (ASOP Global) is encouraged to see the inclusion of critical consumer health and safety protections in the America Competes in Manufacturing, Pre-Eminence in Technology, and Economic Strength Act (America COMPETES Act) introduced in the House this week.
The Alliance for Safe Online Pharmacies (ASOP Global) applauds Sen. Amy Klobuchar (D-MN), Sen. Marco Rubio (R-FL), Rep. Bobby Rush (D-IL), and Rep. David McKinley (R-WV) for the bicameral introduction of the bipartisan Domain Reform for Unlawful druG Sellers Act (DRUGS Act).
The Alliance for Safe Online Pharmacies (ASOP Global) applauds Sens. Marco Rubio (R-FL) and Amy Klobuchar (D-MN) for introducing the bipartisan S.3399 Domain Reform for Unlawful druG Sellers Act (DRUGS Act) yesterday
The Alliance for Safe Online Pharmacies (ASOP Global) applauds the Senate Commerce Subcommittee on Consumer Protection, Product Safety, and Data Security for calling attention to the dangers of deadly drugs easily obtained online.
ASOP Global applauds Congress for moving the INFORM Consumers Act quickly through the legislative process and urges the bill’s swift passage to send a powerful message to online criminals that they can no longer act anonymously and without punishment.
ASOP Global joins members of the American Pharmacists Association (APhA) and American Society of Health-System Pharmacists (ASHP), along with the American Medical Association (AMA), in warning against the ordering, prescribing, or dispensing of ivermectin to prevent or treat COVID-19 outside of a clinical trial.
The Alliance for Safe Online Pharmacies (ASOP Global) will participate in the third U.S. Food and Drug Administration (FDA) Online Opioid Summit. The Summit provides a critical forum for experts from academia, government, private, and nonprofit sectors to collaborate on ways to detect and reduce the availability of opioids on the internet.
The Alliance for Safe Online Pharmacies in the EU (ASOP EU), along with six health-centered organizations, co-signed a letter to members of the European Parliament and the European Council requesting the expansion of the proposed Digital Services Act (DSA) to include online intermediaries.
According to a new national survey the ASOP Global Foundation commissioned from Abacus Data, nearly half of American consumers are willing to risk threats to their health by purchasing medications from unregulated online sources for the sake of more convenience and lower prices. Further, U.S drug importation policies give consumers a false sense of security, leading many to misbelieve that all Canadian medicines sold online are safe and legitimate. Alarmingly, more than one-third of consumers polled say they would knowingly ignore explicit government prohibitions from buying medicines from Canadian online pharmacies because of their misperceptions that they can safely access cheaper medications from sources abroad.
Friday, President Biden issued an Executive Order that directs the Food and Drug Administration (FDA) to work with states and tribes on plans to import prescription drugs from Canada. In response, Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
The Alliance for Safe Online Pharmacies issued the following statement in response to the Department of Health and Human Services announcement that it will revoke a Trump-era call for proposals to create pathways for personal prescription drug and insulin importation from other countries.
The Alliance for Safe Online Pharmacies issued the following statement in support of the “Stopping Harmful Offers on Platforms by Screening Against Fakes in E-commerce Act” (SHOP SAFE Act) and this week’s congressional hearing on the legislation.
the Alliance for Safe Online Pharmacies issued the following statement in support of the bipartisan Integrity, Notification, and Fairness in Online Retail Marketplaces for Consumers Act (INFORM Consumers Act).
The European Alliance for Access to Safe Medicines (EAASM) has published its report ‘Patient Safety and the Implementation of the Falsified Medicines Directive in the Hospital Environment: Practical solutions and benefits’. Read the full release here.
The Alliance for Safe Online Pharmacies issued the following statement about yesterday’s joint hearing on disinformation and the role of social media before the Subcommittee on Communications and Technology and the Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce.
Today, the Alliance for Safe Online Pharmacies issued the following statement in response to the United States Senate’s confirmation of Department of Health and Human Services Secretary Xavier Becerra.
The Alliance for Safe Online Pharmacies issued the following statement in response to the reintroduction of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).
ASOP Global Applauds NTIA for Urging Congress to Protect Americans Online January 6, 2021 As a member of the Coalition for a Secure and Transparent Internet (CSTI), the Alliance for Safe Online Pharmacies (ASOP Global) signed recent letters applauding the National Telecommunications and Information Administration (NTIA) for calling on the House and Senate to address open access to accurate WHOIS data.
ASOP Global Commends U.S. Attorney Hur for Fighting Against COVID-19 Fraud December 21, 2020 In response to the recent seizure by the U.S. Attorney’s Office for the District of Maryland of websites for fraudulently posing as legitimate biotechnology companies actively developing treatments for COVID-19, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Urges Consumers to Remain Aware of COVID-19 Fraud December 11, 2020 In response to the anticipated emergency use authorizations (EUAs) for several COVID-19 vaccines and availability of a direct-to-consumer COVID-19 test system, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement.
ASOP Global Statement of Opposition to Drug Importation Rule November 30, 2020 In response to the U.S. Food and Drug Administration’s (FDA) Importation of Prescription Drugs Final Rule taking effect today, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement of opposition.
ASOP Global Statement on New Section 230 Reform Bill September 29, 2020 The Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement in response to the introduction today of the See Something Say Something Online Act by Senators Joe Manchin (D-WV) and John Cornyn (R-TX).
In response to letters sent by Senators Mazie Hirono (D-Hawaii), Cory Booker (D-N.J.) and Maggie Hassan (D-N.H.) calling on domain name registrars and hosts to fight scams and misinformation during the COVID-19 crisis, the Alliance for Safe Online Pharmacies (ASOP Global) issued the following statement today.
In response to the newly released report by the European Union Intellectual Property Office (EUIPO) and the Organisation for Economic Cooperation and Development (OECD) entitled “Illicit Trade in Counterfeit Pharmaceutical Products,” the Alliance for Safe Online Pharmacy in the EU (ASOP EU) applauds the research conducted to better highlight and quantify the pervasive threat of illegal online drug sellers.